Bank of Montreal’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,145
| Closed | -$271K | – | 4836 |
|
|
2020
Q4 | $271K | Buy |
2,145
+1,191
| +125% | +$150K | ﹤0.01% | 2618 |
|
|
2020
Q3 | $70K | Sell |
954
-367
| -28% | -$26.9K | ﹤0.01% | 2880 |
|
|
2020
Q2 | $65K | Buy |
1,321
+871
| +194% | +$42.9K | ﹤0.01% | 2942 |
|
|
2020
Q1 | $19K | Sell |
450
-1,419
| -76% | -$59.9K | ﹤0.01% | 2977 |
|
|
2019
Q4 | $107K | Buy |
1,869
+449
| +32% | +$25.7K | ﹤0.01% | 2960 |
|
|
2019
Q3 | $51K | Buy |
1,420
+35
| +3% | +$1.26K | ﹤0.01% | 3137 |
|
|
2019
Q2 | $43K | Buy |
1,385
+835
| +152% | +$25.9K | ﹤0.01% | 3317 |
|
|
2019
Q1 | $13K | Buy |
550
+447
| +434% | +$10.6K | ﹤0.01% | 3402 |
|
|
2018
Q4 | $1K | Buy |
103
+53
| +106% | +$515 | ﹤0.01% | 4233 |
|
|
2018
Q3 | $0 | Buy |
+50
| New | – | ﹤0.01% | 4520 |
|